Nalaganje...

Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas

INTRODUCTION: The tight junction molecule Claudin 18.2 is selectively expressed in healthy and malignant gastric epithelial tissue and is a promising therapy target for high Claudin 18.2 expressing adenocarcinomas of the esophagogastric junction and stomach (AEG/S). METHODS: This study analyzed the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Transl Oncol
Main Authors: Arnold, A., Daum, S., von Winterfeld, M., Berg, E., Hummel, M., Rau, B., Stein, U., Treese, C.
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7577914/
https://ncbi.nlm.nih.gov/pubmed/32488802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-020-02380-0
Oznake: Označite
Brez oznak, prvi označite!